Live data from Hacker News

Launch HN: InpharmD (YC W21) – curated drug information for doctors

news.ycombinator.com

1–10 of 74 posts

Launch HN: InpharmD (YC W21) – curated drug information for doctors

#1
Hi HN-

My name is Ashish, and I’m the CEO/ co founder of InpharmD (https://inpharmd.com). We take questions from doctors and return curated, evidence - based answers.

I was a clinical pharmacist offering a remote service from a University for 10 years. Ask us anything, we begged, and our team of pharmacists, residents, and students would look it up, get through the paywalls, and provide the answer.

I passed out business cards around local hospitals. They were lost over time.

Then I passed out business cards with magnets. They stuck around, but there aren’t that many places in the hospital with the magnetic surfaces.

Eventually, people stored our number, but we’d ask so many questions when they called, they couldn’t ask theirs: who are you, where are you calling from, what’s your email, spell it, etc, etc, etc. Often, they’d hang up on us, and I don’t blame them. The average doctor now sees five patients an hour.

I realized I wasn’t alone, and hundreds of other academicians, all leading their own teams, had the same problem. So, we formed a network and interviewed hundreds of our customers about how they’d ideally interact with us. What we needed to build was simple: one touch request.

My co - founder Tulasee built that and since, we learned that AI can transcribe PDFs faster (but not yet better) than our pharmacists. We started with 5,000 of our own study abstracts, assigned weights for corresponding content in their respective PDFs, and now we continuously reassign the weights until the algorithm can completely make our own abstracts. Our latest test revealed 94% accuracy against a matched human control, but with medical information, this will need to be 100% before we can rely on it.

We think Watson was a missed opportunity, so we called our algorithm Sherlock. We’re launching a partnership with the American Society of Health-System Pharmacists® (ASHP- https://ashp.org), using their database of 1,300 vetted drug monographs, so Sherlock can field questions at the point of care.

We’ve been fortunate to find early adopter health systems to pay for our service: WellStar, Ochsner, University of Maryland, Georgia DPH, and St Francis. We’re typically compared to the cost of their healthcare providers manually searching, and we end up cheaper.

We love this community and we’d welcome your ideas/ experiences/ feedback on what we’re building!

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#3
Love the idea, I work in specialty pharma and getting concise information to the pharmacists has become critical. Physicians rely heavily on pharmacists to call the shots on treatment plans now more than ever.

We built our own in house solution to this exact problem, but its maintained by our own clinical staff, it costs us north of $300k a year to maintain it! This only works of course because we have over 150 specialty pharmacies in our 'network' so we have volume to help keep up with costs.

I could honestly see us leveraging a solution like this at some point in the future, and probably anybody running fewer than 10 specialty pharmacies needs a solution like this.

Good luck to you guys!

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#4
I’m not really looking to buy, but given both my own job and that of my wife, I am curious.

After reading your description, and watching the video on you website, I can safely say: I have no idea what service you provide.

Adding example question might help.

In Denmark the government office for medicin provide a free service where you’re able to look up all approved drugs, their usage, side effects, treatment plan and so on. It that what you provide or does it go further than that?

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#6

I’m not in this space, so just out of curiosity what does this cover that Up To Date doesn’t? And/or What are some examples of questions doctors might ask? Thanks!

This is my question.

And it comes down to liability as well. Basing your treatment decisions on UpToDate or NCCS guidelines or Cochrane Reviews is pretty defensible. But basing it on the findings of an AI start up? How is that being addressed?

But don’t get me wrong. I think there is a lot of value in physicians having easy access to pharmacists to discuss treatment options. Right now that doesn’t happen that easily.

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#8
post #3

Love the idea, I work in specialty pharma and getting concise information to the pharmacists has become critical. Physicians rely heavily on pharmacists to call the shots on treatment plans now more than ever. We built our own in house solution to this exact problem, but its maintained by our own clinical staff, it costs us north of $300k a year to maintain it! This only works of course because we have over 150 speci…

Thank you and yes! Medical education is mostly diagnostics and pharmacy education is mostly therapeutics. The most forward thinking health systems are relying on pharmacists to guide treatment decisions. And I’m sure you see this with specialty meds in particular.

And WOW re: $300k per year. I’m certain we could do this for a fraction of that cost. Ashish at InpharmD dot com :-)

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#9

I’m not in this space, so just out of curiosity what does this cover that Up To Date doesn’t? And/or What are some examples of questions doctors might ask? Thanks!

We get this one a bunch; Up to Date is pretty awesome.

Public data + our data shows only ~1/2 of clinical questions can be answered by Up to Date (or references like them).

Those online compendia employ a small team of credible authors + have massive scale, so they focus on the mainstream questions.

Our custom solution is designed around the long tail of emerging or complex questions.

For example, if you want to know about dexamethasone 4mg for early stage COVID, Up to Date will have it. But if you want to know about dexamethasone 20 mg, you’re faced with doing this literature search on PubMed (which = 2 hours + 4 journals) .

We get this question a lot, and really appreciate you surfacing it here. We made this into a FAQ for anyone that prefers to visualize it: https://www.inpharmd.com/faq

Maybe this is how any startup takes on any large incumbent? IDK. We love your collective wisdom, we learn a ton from you all.

Re: Launch HN: InpharmD (YC W21) – curated drug information for doctors

#10
post #6

I’m not in this space, so just out of curiosity what does this cover that Up To Date doesn’t? And/or What are some examples of questions doctors might ask? Thanks!

This is my question. And it comes down to liability as well. Basing your treatment decisions on UpToDate or NCCS guidelines or Cochrane Reviews is pretty defensible. But basing it on the findings of an AI start up? How is that being addressed? But don’t get me wrong. I think there is a lot of value in physicians having easy access to pharmacists to discuss treatment options. Right now that doesn’t happen that easily.

Totally agree- before we started doing anything we had to understand what we could and couldn't say. We probably interviewed as many lawyers as potential customers !

The consequences of wording something wrongly are huge.

To be clear, we stop short of making recommendations. Our goal is to give the provider all the info she needs to make her own evidence informed decision.

Post reply on HN